Procedures for measuring factor D activity and the potency of factor D inhibitors

• 1. 测量因子D活性和因子D抑制剂效力的方法 [P] . 中国专利： CN108513585A . 2018-09-07
• 2. 调节肝细胞生长因子(分散因子)活性的方法和肝细胞生长因子(分散因子)活性的小分子调节剂组合物 [P] . 中国专利： CN102149379A . 2011-08-10
• 3. Methods for measuring D factor activity and the potency of D factor inhibitors [P] . JP6911026B2 . 2021-07-28

  机译： 测量D因子活性的方法和D因子抑制剂的效力

• 4. Methods of measuring factor D activity and potency of factor D inhibitors [P] . 美国专利： US10591481B2 . 2020-03-17

  机译： 测量因子D活性和因子D抑制剂效能的方法

• 5. METHODS OF MEASURING FACTOR D ACTIVITY AND POTENCY OF FACTOR D INHIBITORS [P] . PL3368682T3 . 2020-05-18

  机译： 测量因子D抑制剂的活性和强度的方法

• 1. Effect of radiofrequency ablation combined with transcatheter arterial chemoembolization on inflammatory factors, oxidative stress response factors and tumor activity factors in patients with primary liver cancer [J] . Kun Yang, Xue-Wen Wang, Zhao Lai, 海南医科大学学报（英文版） . 2017,第004期
• 2. Effect of radiofrequency ablation combined with transcatheter arterial chemoembolization on inflammatory factors, oxidative stress response factors and tumor activity factors in patients with primary liver cancer [J] . Kun Yang, Xue-Wen Wang, Zhao Lai, 海南医科大学学报(英文版) . 2017,第004期
• 3. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency. [J] . Wang NC, Venkatapathy R, Bruce RM, Regulatory Toxicology and Pharmacology: RTP . 2011,第2期
• 4. Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity [J] . Harrold Leslie R., Stolshek Bradley S., Rebello Sabrina, The Journal of rheumatology . 2018,第1期
• 5. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy followingn tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China [J] . Jieruo Gu Rheumatology . 2011,第8期
• 6. Study on the inhibiting factors of the activated sludge activity of hexavalent chromium based on the change of dissolved oxygen [C] . Wen-Yu Zhao, Zheng Zhao, Mei-Juan Xu, Annual International Forum on Energy, Environmental and Sustainable Ecosystem Development . 2017
• 7. Understanding the molecular factors governing inhibitor potency and oxygen activation in copper amine oxidases. [D] . Shepard, Eric Michael. 2006
• 8. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register [O] . Gary J Macfarlane, Ross I R MacDonald, Ejaz Pathan, -1
• 9. Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa [O] . Matthieu Bourdin, Delphine Perrotin, Olivier Mathieu, 2021

• 1. Aged Garlic Extract and One of the Constituent, (+)-(2S,3R)-Dehydrodiconiferyl Alcohol, Inhibits Alkaline Phosphatase Activity Induced by Inflammation Factors in Human Vascular Smooth Muscle Cells [J] . Takahiro Yamakawa ,Toshiaki Matsutomo ,Thomas Hofmann . 食品与营养科学（英文） . 2014,第2期
• 2. CONDITIONED MEDIUM OF HUMAN NASOPHARYNGEAL CARCINOMA EPITHELIOID CELL LINE CNE_(1) CONTAINED THE ACTIVITIES OF TRANSFORMED GROWTH-INHIBITING FACTORS [J] . 陆一瓴 ,徐永华 . 中国癌症研究：英文版 . 1990,第3期
• 3. Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cells [J] . Hong Jin ,Wen-Bing Qiu ,Yi-Fang Mei . 亚洲男性学杂志:英文版 . 2009,第2期
• 4. 影响活性碳滤毒罐效能因子评估研究 [C] . 林志威 ,陈志杰 . 第八届全国气溶胶会议暨第二届海峡两岸气溶胶科技研讨会 . 2005
• 5. 角质细胞生长因子(KGF)的表达及其生物学活性研究和成纤维细胞生长因子受体(FGFR)抑制剂稳定转染筛选模型的建立 [A] . 许莉妍 . 2009